Exploiting <scp>DNA</scp> repair defects in colorectal cancer
Nicole M. Reilly(Fondazione Piemontese per la Ricerca sul Cancro Onlus), Alberto Bardelli(Candiolo Cancer Institute)
Cited by 134
Related Papers
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
|Nature Communications|2015|305
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial
|Nature Medicine|2022|251
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
|Nature Communications|2016|211
Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
|Nature Communications|2015|128
TGFα and Amphiregulin Paracrine Network Promotes Resistance to EGFR Blockade in Colorectal Cancer Cells
|Clinical Cancer Research|2014|114